Chromosomal instability and telomere shortening in long-term culture of hematopoietic stem cells: Insights from a cell culture model of RPS14 haploinsufficiency

Cytogenetic and Genome Research

Volumn 142, Issue 1, 2013, Pages 14-20

  Thomay, K ^a   Schienke, A ^a   Vajen, B ^a   Modlich, U ^a   Schambach, A ^a   Hofmann, W ^a   Schlegelberger, B ^a   Gohring G ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cell culture; Chromosomal instability; Hematopoietic stem cells; Myelodysplastic syndrome; Telomeres

Indexed keywords

CD34 ANTIGEN; SHORT HAIRPIN RNA; TELOMERASE;

ARTICLE; ARTIFACT; CELL FATE; CHROMOSOMAL INSTABILITY; CHROMOSOME 5Q; CHROMOSOME ANALYSIS; CLONAL VARIATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; HAPLOINSUFFICIENCY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; NORMAL HUMAN; PRIORITY JOURNAL; TELOMERE SHORTENING; TERT GENE; CD34+ CELL; CELLS BY BODY ANATOMY; CHROMOSOME BREAKAGE; COMPARATIVE STUDY; DNA DAMAGE; FLUORESCENCE IN SITU HYBRIDIZATION; K562 CELL LINE; METAPHASE; NEWBORN; STEM CELL CULTURE; TELOMERE HOMEOSTASIS; WESTERN BLOTTING;

EID: 84891154448     PISSN: 14248581     EISSN: 1424859X     Source Type: Journal    
DOI: 10.1159/000356096     Document Type: Article

References (23)

1. Andrade PZ, dos Santos F, Almeida-Porada G, da Silva CL, S Cabral JM: Systematic delineation of optimal cytokine concentrations to expand hematopoietic stem/progenitor cells in coculture with mesenchymal stem cells. Mol Biosyst 6: 1207-1215 (2010).
2. Bartolović K, Balabanov S, Berner B, Bühring HJ, Komor M, et al: Clonal heterogeneity in growth kinetics of CD34+CD38- human cord blood cells in vitro is correlated with gene expression pattern and telomere length. Stem Cells 23: 946-957 (2005). (Pubitemid 41170950)
3. Drexler HG, Dirks WG, Macleod RA: Many are called MDS cell lines: one is chosen. Leuk Res 33: 1011-1016 (2009).
4. Durkin SG, Glover TW: Chromosome fragile sites. Annu Rev Genet 41: 169-192 (2007).
5. Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, et al: Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 451: 335-339 (2008).
6. Gadalla SM, Savage SA: Telomere biology in hematopoiesis and stem cell transplantation. Blood Rev 25: 261-269 (2011).
7. Gammaitoni L, Weisel KC, Gunetti M, Wu KD, Bruno S, et al: Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication. Blood 103: 4440-4448 (2004). (Pubitemid 38745969)
8. Ge J, Cai H, Tan WS: Chromosomal stability during ex vivo expansion of UCB CD34 + cells. Cell Prolif 44: 550-557 (2011).
9. Göhring G, Giagounidis A, Büsche G, Kreipe HH, Zimmermann M, et al: Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression. Ann Hematol 89: 365-374 (2010).
10. Göhring G, Lange K, Hofmann W, Nielsen KV, Hellström-Lindberg E, et al: Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide. Leukemia 26: 356-358 (2012).
11. Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 144: 646-674 (2011).
12. Hogge DE, Lansdorp PM, Reid D, Gerhard B, Eaves CJ: Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor. Blood 88: 3765- 3773 (1996). (Pubitemid 26383098)
13. ISCN (2009): An International System for Human Cytogenetic Nomenclature, Shaffer LG, Slovak ML, Campbell LJ (eds) (Karger, Basel 2009).
14. Jädersten M, Saft L, Smith A, Kulasekararaj A, Pomplun S, et al: TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression. J Clin Oncol 29: 1971-1979 (2011).
15. Lange K, Holm L, Vang Nielsen K, Hahn A, Hofmann W, et al: Telomere shortening and chromosomal instability in myelodysplastic syndromes. Genes Chromosomes Cancer 49: 260-269 (2010).
16. Lefort N, Perrier AL, Laâbi Y, Varela C, Peschanski M: Human embryonic stem cells and genomic instability. Regen Med 4: 899-909 (2009).
17. Moon SH, Kim JS, Park SJ, Lim JJ, Lee HJ, et al: Effect of chromosome instability on the maintenance and differentiation of human embryonic stem cells in vitro and in vivo. Stem Cell Res 6: 50-59 (2011).
18. Ozeri-Galai E, Bester AC, Kerem B: The complex basis underlying common fragile site instability in cancer. Trends Genet 28: 295-302 (2012).
19. Prockop DJ, Keating A: Relearning the lessons of genomic stability of human cells during expansion in culture: implications for clinical research. Stem Cells 30: 1051-1052 (2012).
20. Ross AL, Leder DE, Weiss J, Izakovic J, Grichnik JM: Genomic instability in cultured stem cells: associated risks and underlying mechanisms. Regen Med 6: 653-662 (2011).
21. Schlegelberger B, Metzke S, Harder S, Zühlke- Jenisch R, Zhang Y, Siebert R: Classical and molecular cytogenetics of tumor cells, in Wegner RD (ed): Diagnostic Cytogenetics, pp 151-185 (Springer Verlag, Heidelberg 1999).
22. Schmidt M, Hoffmann G, Wissler M, Lemke N, Müssig A, et al: Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum Gene Ther 12: 743-749 (2001). (Pubitemid 32692340)
23. Tehranchi R, Woll PS, Anderson K, Buza-Vidas N, Mizukami T, et al: Persistent malignant stem cells in del(5q) myelodysplasia in remission. N Eng J Med 363: 1025-1037 (2010).